Genevault offers a secure federated query platform for analyzing distributed genomic, phenomic, and Real-World Data. Our solution enables researchers to gain comprehensive health insights while ensuring data privacy and sovereignty, accelerating the development of equitable precision medicine.
Funding
Funding not disclosed
Founders
Product
Problem
Medical research faces an "Intelligence Gap" due to a lack of diversity in genomic data, leading to flawed precision medicine and missed scientific discoveries. This data is often scattered, isolated, and subject to complex privacy and security regulations, hindering comprehensive analysis.
Solution
Genevault provides a secure federated query platform that enables researchers to analyze genomic, phenomic, and Real-World Data without physically moving it. Our technology allows analysis to occur where the data resides, ensuring compliance with privacy laws and data sovereignty for custodians. By integrating these diverse data types, Genevault facilitates a more complete understanding of human health, accelerating the development of equitable precision medicine.
Target Audience
Genevault serves pharmaceutical companies, academic research institutions, and biobanks that require access to diverse and ethically sourced genomic data for precision medicine research.
Features
- Secure federated query engine for distributed data analysis without data movement.
- Integration of genomic, phenomic, and Real-World Data for comprehensive health insights.
- Compliance with international privacy regulations (e.g., GDPR, HIPAA) and data sovereignty principles.
- Platform designed to maintain data custodians' control and ethical data usage.
- Facilitates analysis of historically underrepresented populations to address data diversity gaps.
- Supports secure, aggregated, and anonymized result generation for research applications.